These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. miR-145-5p is associated with smoke-related chronic obstructive pulmonary disease via targeting KLF5. Dang X; Yang L; Guo J; Hu H; Li F; Liu Y; Pang Y Chem Biol Interact; 2019 Feb; 300():82-90. PubMed ID: 30639269 [TBL] [Abstract][Full Text] [Related]
24. miR-141 and miR-200a, Revelation of New Possible Players in Modulation of Th17/Treg Differentiation and Pathogenesis of Multiple Sclerosis. Naghavian R; Ghaedi K; Kiani-Esfahani A; Ganjalikhani-Hakemi M; Etemadifar M; Nasr-Esfahani MH PLoS One; 2015; 10(5):e0124555. PubMed ID: 25938517 [TBL] [Abstract][Full Text] [Related]
25. Micro-RNA 18b and interleukin 17A profiles in relapsing remitting multiple sclerosis. Mohamed MS; Nahrery EMAE; Shalaby N; Hussein M; Aal RAE; Mohamed MM Mult Scler Relat Disord; 2019 Feb; 28():226-229. PubMed ID: 30623862 [TBL] [Abstract][Full Text] [Related]
26. Connection of miR-185 and miR-320a expression levels with response to interferon-beta in multiple sclerosis patients. Mousavi SR; Tahmasebivand M; Khorrami M; Ayromlou H; Khalili SK; Khorvash F; Rikhtegar R; Khademi B; Bahmanpour Z; Emamalizadeh B Mult Scler Relat Disord; 2020 Sep; 44():102264. PubMed ID: 32554287 [TBL] [Abstract][Full Text] [Related]
27. CSF microRNAs discriminate MS activity and share similarity to other neuroinflammatory disorders. Perdaens O; Dang HA; D'Auria L; van Pesch V Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 32033981 [TBL] [Abstract][Full Text] [Related]
28. MicroRNA-572 expression in multiple sclerosis patients with different patterns of clinical progression. Mancuso R; Hernis A; Agostini S; Rovaris M; Caputo D; Clerici M J Transl Med; 2015 May; 13():148. PubMed ID: 25947625 [TBL] [Abstract][Full Text] [Related]
29. Circulating Plasma Extracellular Vesicles from Septic Mice Induce Inflammation via MicroRNA- and TLR7-Dependent Mechanisms. Xu J; Feng Y; Jeyaram A; Jay SM; Zou L; Chao W J Immunol; 2018 Dec; 201(11):3392-3400. PubMed ID: 30355788 [TBL] [Abstract][Full Text] [Related]
30. Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing. Keller A; Leidinger P; Steinmeyer F; Stähler C; Franke A; Hemmrich-Stanisak G; Kappel A; Wright I; Dörr J; Paul F; Diem R; Tocariu-Krick B; Meder B; Backes C; Meese E; Ruprecht K Mult Scler; 2014 Mar; 20(3):295-303. PubMed ID: 23836875 [TBL] [Abstract][Full Text] [Related]
31. Profiling of Canonical and Non-Traditional Cytokine Levels in Interferon-β-Treated Relapsing-Remitting-Multiple Sclerosis Patients. D'Angelo C; Reale M; Costantini E; Di Nicola M; Porfilio I; de Andrés C; Fernández-Paredes L; Sánchez-Ramón S; Pasquali L Front Immunol; 2018; 9():1240. PubMed ID: 29915590 [TBL] [Abstract][Full Text] [Related]
32. JCPyV microRNA in plasma inversely correlates with JCPyV seropositivity among long-term natalizumab-treated relapsing-remitting multiple sclerosis patients. Basnyat P; Virtanen E; Elovaara I; Hagman S; Auvinen E J Neurovirol; 2017 Oct; 23(5):734-741. PubMed ID: 28831768 [TBL] [Abstract][Full Text] [Related]
33. Circular RNA CEP128 promotes bladder cancer progression by regulating Mir-145-5p/Myd88 via MAPK signaling pathway. Sun M; Zhao W; Chen Z; Li M; Li S; Wu B; Bu R Int J Cancer; 2019 Oct; 145(8):2170-2181. PubMed ID: 30939216 [TBL] [Abstract][Full Text] [Related]
34. The identification of up-regulated ebv-miR-BHRF1-2-5p targeting MALT1 and ebv-miR-BHRF1-3 in the circulation of patients with multiple sclerosis. Wang YF; He DD; Liang HW; Yang D; Yue H; Zhang XM; Wang R; Li B; Yang HX; Liu Y; Chen Y; Duan YX; Zhang CY; Chen X; Fu J Clin Exp Immunol; 2017 Jul; 189(1):120-126. PubMed ID: 28253538 [TBL] [Abstract][Full Text] [Related]
35. Identification of MyD88 as a novel target of miR-155, involved in negative regulation of Helicobacter pylori-induced inflammation. Tang B; Xiao B; Liu Z; Li N; Zhu ED; Li BS; Xie QH; Zhuang Y; Zou QM; Mao XH FEBS Lett; 2010 Apr; 584(8):1481-6. PubMed ID: 20219467 [TBL] [Abstract][Full Text] [Related]
37. Down-regulation of miR-10a-5p in synoviocytes contributes to TBX5-controlled joint inflammation. Hussain N; Zhu W; Jiang C; Xu J; Wu X; Geng M; Hussain S; Cai Y; Xu K; Xu P; Han Y; Sun J; Meng L; Lu S J Cell Mol Med; 2018 Jan; 22(1):241-250. PubMed ID: 28782180 [TBL] [Abstract][Full Text] [Related]
38. miR-15a and 16-1 are downregulated in CD4+ T cells of multiple sclerosis relapsing patients. Lorenzi JC; Brum DG; Zanette DL; de Paula Alves Souza A; Barbuzano FG; Dos Santos AC; Barreira AA; da Silva WA Int J Neurosci; 2012 Aug; 122(8):466-71. PubMed ID: 22463747 [TBL] [Abstract][Full Text] [Related]
39. Selected extracellular microRNA as potential biomarkers of multiple sclerosis activity--preliminary study. Kacperska MJ; Jastrzebski K; Tomasik B; Walenczak J; Konarska-Krol M; Glabinski A J Mol Neurosci; 2015 May; 56(1):154-63. PubMed ID: 25487315 [TBL] [Abstract][Full Text] [Related]
40. The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis. Mandolesi G; Rizzo FR; Balletta S; Stampanoni Bassi M; Gilio L; Guadalupi L; Nencini M; Moscatelli A; Ryan CP; Licursi V; Dolcetti E; Musella A; Gentile A; Fresegna D; Bullitta S; Caioli S; Vanni V; Sanna K; Bruno A; Buttari F; Castelli C; Presutti C; De Santa F; Finardi A; Furlan R; Centonze D; De Vito F Cells; 2021 Feb; 10(2):. PubMed ID: 33562569 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]